We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
During the last 30 years, the incidence of oesophagealadenocarcinoma has increased rapidly.
2
Methods: Consecutive patients with oesophagealadenocarcinoma who underwent PET-CT before neoadjuvant chemotherapy and resection were included.
3
Patients with Barrett's oesophagus have an increased risk of developing oesophagealadenocarcinoma and should be kept under surveillance.
4
There are few epidemiological data on the dietary risk factors of Barrett's oesophagus, a precursor of oesophagealadenocarcinoma.
5
The incidence of oesophagealadenocarcinoma (EADC) is rapidly increasing in Western countries and obesity is thought to be a major risk factor.
1
Incidence rates for adenocarcinomaoftheesophagus and gastric cardia have been rising rapidly.
2
Methods and materials: Patients with adenocarcinomaoftheesophagus without distant organ metastases were eligible.
3
Incidence increased for several cancers, including pancreas, kidney, and adenocarcinomaoftheesophagus, which are associated with excess weight.
4
Patients and methods: Sixty-one patients with advanced, surgically unresectable, or metastatic squamous cell or adenocarcinomaoftheesophagus were treated.
5
A retrospective analysis should compare the two operative approaches, transhiatal or transthoracic resection in patients suffering from adenocarcinomaoftheesophagus.
1
Barrett's esophagus is an important step in the pathway to esophagealadenocarcinoma.
2
Context: The incidence of esophagealadenocarcinoma is rising and has surpassed squamous cell carcinoma.
3
Future studies of trastuzumab in esophagealadenocarcinoma are indicated.
4
Barrett's esophagus (BE) is the principal risk factor for esophagealadenocarcinoma.
5
Barrett's esophagus is the precursor lesion for esophagealadenocarcinoma.